- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: IBI310
Total 363 results
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingAdvanced Biliary Tract CancerChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorChina
-
Harbin Medical UniversityInnovent Biologics (Suzhou) Co. Ltd.Not yet recruitingAdvanced Gastric/Gastroesophageal Junction Adenocarcinoma
-
Innovent Biologics (Suzhou) Co. Ltd.Innovent Biologics (USA), Inc.WithdrawnMetastatic Cutaneous Melanoma | Unresectable Cutaneous MelanomaUnited States, Germany, France, Australia, Spain, Switzerland, United Kingdom
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedAcral Melanoma That Has Been Removed by SurgeryChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedNSCLC (Non-small-cell Lung Cancer)China
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Peking UniversityInnovent Biologics (Suzhou) Co. Ltd.UnknownAdvanced Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
Peking UniversityRecruitingNeuroendocrine NeoplasmChina
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedAdvanced Cutaneous Squamous Cell CarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingAdvanced Malignant TumorsChina
-
Tongji HospitalWuhan University; Henan Cancer Hospital; Qilu Hospital of Shandong University; Hubei... and other collaboratorsRecruitingOvarian Clear Cell CarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingThyroid Eye Disease, TEDChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingSolid TumorsAustralia
-
Innovent Biologics (Suzhou) Co. Ltd.Unknown
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Hunan Province Tumor HospitalXiangya Hospital of Central South UniversityRecruiting
-
The First Affiliated Hospital of Zhengzhou UniversityNot yet recruitingEsophageal Squamous Cell Carcinoma (ESCC) | PD-1 InhibitorsChina
-
Peking University People's HospitalActive, not recruitingThyroid Associated OphthalmopathyChina
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedCOVID-19United States
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Hunan Province Tumor HospitalRecruitingNon-Small Cell Lung CancerChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingLocally Advanced Unresectable or Metastatic Solid TumorsAustralia
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingMultiple MyelomaAustralia
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingLocally Advanced Unresectable or Metastatic Solid TumorsAustralia
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedCLDN18.2 Positive Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced/Metastatic Solid MalignanciesUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingNeovascular Age-related Macular DegenerationChina